IMedis
AI-powered Quality Assurance Platform for Radiology
Company Overview
Snapshot
Founded in January 2018 by Aviel Blumenfeld and Yitzi Pfeffer, IMedis operates with over 1,000 employees. The company has secured $3.7 million in total capital across three funding rounds from two investors. In January 2021, IMedis received CE approval for its radiology scans in the EU, marking a significant regulatory milestone.
Business overview
IMedis develops an AI-driven cloud-based quality management system specifically designed for radiology departments. The company's core technology aggregates and analyzes data from PACS and RIS to identify and address failure points within the radiology workflow. This approach aims to reduce risk, enhance financial efficiency, and generate new business opportunities for healthcare providers. Its flagship product, Duali-Q, focuses on managing and following up on errors of omission in CT scans of the chest and abdomen, serving markets in Europe, the Americas, and Oceania.
Strategic signal
In January 2021, IMedis received CE approval for its radiology scans in the EU. This regulatory validation is a critical signal for investors, demonstrating the company's ability to meet stringent European health, safety, and environmental protection standards. It signifies market readiness and opens up significant commercial opportunities within the European Union, indicating strong potential for expansion and adoption of its AI-powered diagnostic solutions.
Log in to access full profile ›Company Intelligence Q&A
- When was IMedis founded?
- IMedis was founded in January 2018 by Aviel Blumenfeld and Yitzi Pfeffer.
- What is Duali-Q?
- Duali-Q is IMedis's first commercially available module, designed for the management and follow-up of errors of omission in CT scans of the chest and the abdomen. It has been shown to increase detection rates of life-threatening diseases by 13% in studies.
- What regulatory approval did IMedis receive in 2021?
- In January 2021, IMedis received CE approval for its radiology scans in the EU, allowing its technology to be used in European markets.
- Which investor participated in IMedis's January 2020 funding round?
- In January 2020, IMedis secured funding from ExitValley through an Equity Crowdfunding campaign.
- Which investor led IMedis's April 2018 funding round?
- In April 2018, Sanara Ventures led IMedis's Pre-Seed funding round.